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Edited by Laszlo NagyAbstract The present study investigated the role of selenium in
the regulation of pancreatic beta-cell function. Utilising the
mouse beta-cell line Min6, we have shown that selenium speciﬁ-
cally upregulates Ipf1 (insulin promoter factor 1) gene expres-
sion, activating the 2715 to 1960 section of the Ipf1 gene
promoter. Selenium increased both Ipf1 and insulin mRNA levels
in Min6 cells and stimulated increases in insulin content and
insulin secretion in isolated primary rat islets of Langerhans.
These data are the ﬁrst to implicate selenium in the regulation
of speciﬁc beta-cell target genes and suggest that selenium poten-
tially promotes an overall improvement in islet function.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The essential trace element selenium forms a key constituent
of selenoproteins such as glutathione peroxidases [1] and acts
as a critically important antioxidant in many diﬀerent cell
types [2]. Selenium has also been found to have insulin-mimetic
activities in vitro and in vivo [3] and has been shown to stim-
ulate glucose uptake in adipocytes in vitro [4], restore normo-
glycaemia in streptozotocin-diabetic rats [2] and regulate vital
metabolic processes such as glycolysis and gluconeogenesis [5].
The mechanisms by which selenium exerts these eﬀects are still
relatively unclear, however evidence indicates that selenium
may activate key molecules in the insulin signalling cascade [6].
It has been shown in other tissues that diﬀerent chemical
forms of selenium have diﬀering potencies in their eﬀects on
cellular function [7]. To date, the speciﬁc eﬀects of diﬀerentAbbreviations: ELISA, enzyme-linked immunosorbent assay; FOXA2,
forkhead homeobox A2; GAPDH, glyceraldehyde-3-phosphate dehy-
drogenase; GPx, gluthathione peroxidase; HNF1a, hepatocyte nuclear
factor 1 alpha; IPF1, insulin promoter factor; Na2SeO4, sodium
selenate; Na2SeO3, sodium selenite; Na2SO3, sodium sulﬁte
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function have not been determined. In the present study, we
have utilised the glucose-responsive mouse beta-cell line
Min6 to begin to investigate the speciﬁc eﬀects of selenium
on expression of the key beta-cell transcription factor Ipf1
(insulin promoter factor 1) and on the regulation of insulin
gene expression. In combination with our analysis of the eﬀects
of selenium on insulin content and secretion from isolated rat
islets of Langerhans, the results of the present study indicate
that selenium provokes signiﬁcant changes in pancreatic
beta-cell gene expression, contributing to overall improve-
ments in islet function.2. Materials and methods
2.1. Materials
Cell culture materials, LipofectAMINE and OptiMEM were pur-
chased from Invitrogen (Paisley, UK); luciferin was from Perbio (New-
castle, UK); protein assay reagent was from Bio-Rad (Hemel
Hempstead, UK). All other chemicals and materials were purchased
from Sigma–Aldrich (Dorset, UK).2.2. Cell culture and transfection
Min6 cells were cultured in selenium-free Dulbeccos modiﬁed Ea-
gles medium (DMEM) containing 5 mmol/l glucose. Construct
pGL3-IPF1 contains a 4531 bp fragment of the mouse Ipf1 pro-
moter upstream of the luciferase reporter gene [8]. pGL3-IPFb con-
tains a section of the Ipf1 promoter between 2715 and 1960 bp.
Plasmid DNA was prepared using an Endotoxin-free Maxiprep Kit
(Qiagen, Crawley, UK). Min6 cells were transfected as previously
described [8]. Forty-eight hours post-transfection cells were incu-
bated with either 30 nmol/l sodium selenite (Na2SeO3), 30 nmol/l so-
dium selenate (Na2SeO4) or 30 nmol/l sodium sulﬁte (Na2SO3) for
3 h. Luciferase assays were performed as previously described [8].
Thirty nmol/l was used throughout the present study, based on
the recommended RDA and healthy circulatory concentration of
selenium [9].2.3. RT-PCR
RNA was isolated using the Gen Elute Mammalian Total RNA Kit
(Sigma) according to manufacturers protocols. The following
exon-spanning primers and PCR conditions were utilised: For glyceral-
dehyde-3-phosphate dehydrogenase (Gapdh), 5 0-aagggctcatgaccacagtc-
cat-3 0 and 5 0-caggaaatgagcttcacaaagtt-3 0: 95 C for 5 min, then
25 cycles consisting of 95 C for 30 s, 55 C for 45 s, 72 C for 60 s, with
a ﬁnal step of 72 C for 5 min. For Ipf1, 5 0-atgaatagtgaggagcagta-3 0 and
5 0-tatgcacctcctgcccactg-30: 95 C for 5 min, then 35 cycles consisting of
95 C for 30 s, 58 C for 45 s, 72 C for 45 s, with a ﬁnal step of 72 Cblished by Elsevier B.V. All rights reserved.
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Fig. 1. Sodium selenite (Na2SeO3) stimulates GPx activity in pancre-
atic beta-cells. Min6 cells were stimulated with 30 nmol/l Na2SeO3 for
3 h. Whole cell extracts were prepared and cellular GPx activity was
measured. Graphs represent the combined results from three separate
experiments, where n = 2 within each experiment. Error bars represent
standard deviation, *P < 0.05 compared to the unstimulated control
(white bars).
2334 S.C. Campbell et al. / FEBS Letters 582 (2008) 2333–2337for 5 min. For insulin, 5 0-ccagctataatcagagacca-3 0 and 5 0-gtgtagaa-
gaagccacgct-30: 95 C for 5 min, then 20 cycles of 95 C for 30 s,
58 C for 45 s, 72 C for 45 s, with a ﬁnal step of 72 C for 5 min.
2.4. Western blotting
Whole cell extracts were prepared, fractionated by SDS–PAGE and
Western blotting was carried out all as previously described [8]. The
IPF1 antibody was a kind gift from Dr C.V. Wright (Vanderbuilt Uni-
versity, Nashville, TN). GAPDH antibody was from Autogen Bioclear
(Calne, UK).
2.5. Glutathione peroxidase cellular activity assay
GPx activity was analysed using the glutathione peroxidase cellu-
lar activity assay kit according to the manufacturers protocol (Sig-
ma). Min6 cells seeded at equal densities were stimulated with
30 nmol/l Na2SeO3 for 3 h. Whole cell extracts were prepared using
a low peroxide detergent Triton X-100 and absorbance at 340 nm
was followed in a Hitachi U-2001 Spectrophotometer using the ki-
netic program: wavelength: 340 nm; initial delay: 15 s; interval:
10 s; number of readings: 6 and the DA340/min was determined.
2.6. Rat islet insulin content and secretion
Islets were isolated from 300 g male Wistar rats (Charles River, Mar-
gate, UK) by collagenase P digestion of distended pancreases as previ-
ously described [8]. Islets were hand picked and pre-incubated in
CMRL medium containing 5.6 mmol/l glucose supplemented with
10% Gold FCS (PAA, Somerset, UK), 100 units/ml penicillin,
100 lg/ml streptomycin and ITS-A (Invitrogen) in non-adherent ﬂasks
(Nunc, Hereford, UK) for 24 h at 37 C in a humidiﬁed 5% CO2 incu-
bator. Following washing with Hanks balanced salt solution (PAA),
10 size-matched islets were hand picked and cultured in CMRL med-
ium supplemented with 0.2 g/l human serum albumin, 100 units/ml
penicillin, 100 lg/ml streptomycin with or without 30 nmol/l Na2SeO3,
with six repeats for each condition. Islets were cultured at 37 C in a
humidiﬁed 5% CO2 incubator for 72 h. Supernatants and islets were
collected and stored at 20 C for later insulin determination. Islets
were lysed in PBS by 3 cycles of freeze thawing followed by centrifuga-
tion at 14000 rpm for 5 min. Secreted insulin in the supernatant and
insulin content in the lysates was determined using High Range Rat
Insulin ELISA (Mercodia, Diagenics Ltd., Milton Keynes, UK). Total
protein was determined using Bio-Rad protein assay dye reagent.
2.7. Statistics and densitometry
The data are expressed as means ± S.D. Data were compared using
Students t-test. Densitometry was performed using the TINA v2.09g
software (Raytest, Straubenhardt, Germany). A P-value of less than
0.05 was considered signiﬁcant. *P < 0.05, **P < 0.01.3. Results
3.1. Na2SeO3 signiﬁcantly increases GPx activity in Min6 beta-
cells
Little is currently known about the speciﬁc eﬀects of selenium
on pancreatic beta-cell gene expression and islet cell function.
Min6 cells were stimulated for 3 h with 30 nmol/l Na2SeO3
and whole cell extracts assayed for gluthathione peroxidase
(GPx) activity (Fig. 1). Thirty nmol/l was used throughout
the present study, based on the recommended RDA and
healthy circulatory concentration of selenium [9]. Na2SeO3
addition stimulated a signiﬁcant 5-fold increase in GPx activity
(*P < 0.05), indicating that Min6 beta-cells are signiﬁcantly se-
leno-sensitive.
3.2. Selenium stimulates the Ipf1 gene promoter in Min6 beta-
cells
To study the eﬀect of selenium on Min6 cell gene expression,
we initially utilised the inorganic species Na2SeO3. Min6 cells
were transfected with construct pGL3-IPF1, which containsthe full-length mouse Ipf1 gene promoter; pGL3-IPFb, con-
taining the 2715 to 1960 bp section of the Ipf1 gene pro-
moter shown to direct beta-cell speciﬁc activity of the Ipf1
promoter [8]; or with control construct pGL3, which lacks
the promoter fragment. Upon stimulation of cells with
30 nmol/l Na2SeO3 for 3 h, a 3.5-fold increase (**P < 0.01) in
the activity of the full-length Ipf1 promoter was observed
(Fig. 2A), and a 7-fold increase in the activity of the beta-cell
speciﬁc section of the promoter (**P < 0.01). No eﬀect was ob-
served on the control construct lacking the promoter fragment,
which remained unaﬀected by the presence or absence of sele-
nium.
To determine if the oxidation state of selenium was critical
to the observed eﬀects, we next investigated the eﬀect of
Na2SeO4. Addition of 30 nmol/l Na2SeO4 for 3 h resulted in
a 1.5-fold increase (*P < 0.05) in the activity of the full-length
Ipf1 promoter (Fig. 2B), and a 2-fold increase in the activity
of the beta-cell speciﬁc section of the promoter (*P < 0.05).
No eﬀect was observed on the control construct pGL3. To
establish that selenium, and not the carrier molecule sodium,
was stimulating Ipf1 gene promoter activity, we lastly investi-
gated the eﬀects of Na2SO3, an important control since it has
a similar oxyanion moiety as Na2SeO3 and the same counter
cation (Na), but lacks the selenium ion. No eﬀect of Na2SO3
was observed on either the full-length or beta-cell portion of
the Ipf1 gene promoter (Fig. 2C).
3.3. Selenium stimulates endogenous Ipf1 and insulin mRNA
levels in Min6 beta-cells
To investigate the eﬀect of selenium on endogenous Ipf1
mRNA levels, Min6 cells were incubated ±30 nmol/l Na2SeO3
for 48 h and Ipf1 mRNA levels analysed by semi-quantitative
RT-PCR. Addition of 30 nmol/l Na2SeO3 resulted in a signif-
icant increase in Ipf1 mRNA levels (Fig. 3, panels A and B)
(*P < 0.05). No eﬀect was observed on the control housekeep-
ing gene Gapdh. A signiﬁcant increase in insulin mRNA levels
(Fig. 3, panels C and D) (*P < 0.05) was also observed. IPF1
protein levels were also signiﬁcantly increased (*P < 0.05) in
the presence of Na2SeO3 (Fig. 4, panel A). No eﬀect was ob-
served on the levels of the control protein GAPDH, which re-
mained unaﬀected by the presence or absence of selenium (Fig.
4, panel B).
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Fig. 2. Selenium stimulates the Ipf1 gene promoter in Min6 beta-cells.
Min6 cells were transfected with the construct pGL3-IPF1, which
contains the full-length mouse Ipf1 gene promoter upstream of the
ﬁreﬂy luciferase reporter gene; or with the construct pGL3-IPFb,
which contains the 2715 to 1960 bp section of the Ipf1 gene
promoter previously shown to have beta-cell speciﬁc activity [8]; or
with the control construct pGL3, which lacks the promoter fragment.
Forty-eight hours post-transfection, cells were stimulated for 3 h with
(A) 30 nmol/l Na2SeO3, (B) 30 nmol/l Na2SeO4 or (C) 30 nmol/l
Na2SO3. These compounds were tested as Na2SeO3 and Na2SeO4
contain selenium ions with diﬀering oxidation states, whilst Na2SO3
contains the same sodium counter cation, but with selenium replaced
with sulfur. Cells were harvested and assayed for luciferase enzyme
activity. Values are standardised for protein content, n = 3 for each
value, and error bars represent standard deviation. These results have
been reproduced in at least three separate experiments. *P < 0.05,
**P < 0.01 compared with the unstimulated samples for the same
vector.
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isolated intact rat islets of Langerhans
We lastly examined the eﬀects of selenium on insulin content
and secretion from isolated rat islets of Langerhans. Islets in
batches of ten were incubated ±30 nmol/l Na2SeO3 for 72 h.
Insulin content and secretion from sets of six replicate samples
were analysed by enzyme-linked immunosorbent assay (ELI-
SA) (Fig. 5). Addition of 30 nmol/l Na2SeO3 for 72 h signiﬁ-
cantly increased both insulin content (*P < 0.05 vs. control)
and insulin secretion from the islets (*P < 0.05 vs. control).
No eﬀect was observed on glucose-stimulated insulin secretionin short term (2 h) incubation studies with freshly isolated rat
islets (data not shown).4. Discussion
The present study has shown that the essential trace element
selenium regulates several important aspects of beta-cell and
islet function. We have shown that selenium speciﬁcally upreg-
ulates Ipf1 gene expression, activating the 2715 to 1960 sec-
tion of the Ipf1 gene promoter. In addition, selenium increased
insulin mRNA levels in Min6 cells and stimulated increases in
both insulin content and insulin secretion in isolated primary
rat islets of Langerhans. These data are the ﬁrst to implicate
selenium in the regulation of speciﬁc target genes in pancreatic
beta-cells and suggest that selenium not only stimulates pan-
creatic beta-cell gene expression, but potentially promotes an
overall improvement in islet function.
Our data indicates that selenium activation of the Ipf1 gene
promoter is most marked in the region 2715 to 1960 up-
stream from the transcriptional start site. We have previously
shown that this region is suﬃcient to drive beta-cell speciﬁc
expression of the Ipf1 gene [8]. The transcription factors
responsible for the activation of the promoter by selenium re-
main to be identiﬁed. However, this section of the promoter is
known to bind hepatocyte nuclear factor 1 alpha (HNF1a),
forkhead homeobox A2 (FOXA2), v-maf musculoaponeurotic
ﬁbrosarcoma oncogene homologue A (MAFA), paired box 6
(PAX6) and the IPF1 protein itself [10]. Further work is re-
quired to fully deﬁne the speciﬁc combination of transcription
factors responsible for mediating the eﬀects of selenium in the
current study.
Our results suggest that accessibility to selenium ions may
determine the eﬀects of dietary intake of selenium on pancre-
atic beta-cell function. The observed eﬀects of Na2SeO3 in
the present study were shown to be speciﬁcally due to both
the presence and the oxidation state of the Se ion. Hence so-
dium selenate, which contains selenium in a diﬀerent oxidation
state (Na2SeO4), also stimulated the Ipf1 gene promoter, but to
a lesser extent than Na2SeO3. This observed diﬀerence in mag-
nitude may reﬂect diﬀerences in the accessibility of the sele-
nium ion between these two moieties. Whereas selenite is
readily reduced to selenide (Se2) and subsequently assimilated
into selenoproteins, the reduction of selenate to selenite ap-
pears only to be catalysed by speciﬁc enzymes. These multi-
component molybdo-enzymes catalyse the selective two elec-
tron reduction of selenate to selenite. Cellular metabolism of
selenate in mammalian cells, including its intermediary reduc-
tion to the oxidative state +IV, has previously been implicated
in the magnitude of response to selenium-containing com-
pounds in vivo [11].
Using viologen dyes as an artiﬁcial electron donor in a col-
ourmetric assay we have detected a low level of selenate reduc-
tase activity in pancreatic cell extracts. The rate of auto
oxidation of the viologen dye was routinely determined to be
2.0 nmol [MV]2+ min1 ml1. The selenate dependent rate
of oxidation was determined to be approximately 10-fold
greater than the endogenous rate (20 nmol [MV]2+ min-
1 ml1), suggesting the presence of selenate reductase activity
in the pancreatic extract. No selenate dependent re-oxidation
of methyl viologen was observed in the absence of the pancre-
atic cell extract. Despite the oxidation state of the selenium
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Fig. 3. Sodium selenite (Na2SeO3) stimulates endogenous Ipf1 and insulin mRNA levels in Min6 beta-cells. Min6 cells were incubated in the presence
or absence of 30 nmol/l Na2SeO3 for 48 h. RNA was prepared, 1 lg reverse transcribed and Ipf1 and Gapdh mRNA levels analysed by semi-
quantitative RT-PCR (Panel A). Panel B represents densitometric analyses of 4 separate experiments, with Ipf1 expressed as a ratio to Gapdh. Panel
C represents analysis of insulin mRNA levels under the same conditions. Panel D represents densitometric analyses of four separate experiments,
with insulin expressed as a ratio to Gapdh. Error bars represent standard deviation, *P < 0.05 compared with the unstimulated samples.
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Fig. 4. Sodium selenite (Na2SeO3) stimulates IPF1 protein levels in
pancreatic beta-cells. Min6 cells were incubated in the presence or
absence of 30 nmol/l Na2SeO3 for 48 h. Whole cell extracts were
prepared and 5 lg of each sample was separated by SDS–PAGE and
Western blot analysis performed utilising speciﬁc IPF1 and GAPDH
antibodies (Panel A). Panel B represents densitometric analyses of 3
separate experiments, with IPF1 expressed as a ratio to GAPDH.
Error bars represent standard deviation, *P < 0.05 compared with the
unstimulated samples.
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Fig. 5. Sodium selenite (Na2SeO3) increases insulin content and
secretion from isolated intact rat islets of Langerhans. Isolated rat
islets of Langerhans were separated into batches of 10 islets and
incubated with or without 30 nmol/l Na2SeO3 for 72 h. The graph
represents insulin content (white bars) and secretion (black bars)
corrected for total protein content. Data are expressed as relative fold
increase in comparison to control islets. Bars represent means ± S.D.
of three independent experiments each of which consisted of six
replicates of each condition, *P < 0.05 compared with the control.
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speciﬁc to the selenium ion, as replacement of selenium with
either nitrogen or sulfur was unable to reproduce the stimula-
tory eﬀect on Ipf1 gene expression.GPx has previously been implicated in the protection of pan-
creatic beta-cells from oxidative stress in a model of glucose
toxicity [12], and increased GPx expression has been shown
to positively modulate beta-cell function [13]. The 5-fold in-
crease in GPx activity observed in the present study in re-
sponse to selenium addition is comparable to that observed
in other seleno-sensitive cell types, such as liver cells [14].
The precise role of selenoproteins such as GPx in the modula-
tion of beta-cell gene expression remains to be more fully ex-
plored. Oxidative stress has been shown, in the long term, to
S.C. Campbell et al. / FEBS Letters 582 (2008) 2333–2337 2337decrease pancreatic beta-cell function [15]. Pancreatic islets
and in particular beta-cells have very low amounts of antioxi-
dant enzymes and are therefore very sensitive to oxidative
stress [16]. The beta-cell dysfunction generated by oxidative
stress can largely be attributed to the down regulation of insu-
lin gene transcription and insulin secretion. This occurs as a re-
sult of down regulation of IPF1, a beta-cell speciﬁc
homeodomain transcription factor that plays a vital role in
the transcriptional regulation of insulin production in response
to glucose [8]. Oxidative stress has been shown to down regu-
late both Ipf1 mRNA and protein levels and also decrease the
binding activity of IPF1 to the insulin gene promoter, all of
which contribute to the observed loss of insulin gene expres-
sion. The overall role of selenium in the regulation of beta-cell
gene expression also remains to be fully clariﬁed. It is thought
that the insulin-mimetic eﬀects of selenium may in part be due
to the activation of tyrosine kinases integral to the insulin
signalling cascade [6], but the activation of these signalling
molecules has not been studied in pancreatic beta-cells thus
far.
In the present study, selenium stimulated signiﬁcant in-
creases in both insulin content and insulin secretion in isolated
islets of Langerhans. This is an interesting observation since
many studies have reported potentially protective eﬀects of
selenium in animal models of type 2 diabetes [17] and in
patients with the disease [18]. To date, the speciﬁc molecular
mechanisms driving this protection have not been identiﬁed.
Since increasing IPF1 protein levels drive the initiation of insu-
lin gene transcription, allowing the replenishment of intracellu-
lar insulin content and increased insulin secretion, it seems
reasonable to hypothesise that the reported positive eﬀects of
selenium on beta-cell function may be mediated through initial
changes in Ipf1 gene expression and IPF1 protein levels.
The current recommended dietary intake of selenium in hu-
mans is between 55 and 75 lg per day [19]; however, many
areas of the globe, including the UK, have intakes well below
this recommended level. Although the beneﬁcial eﬀects of sele-
nium remain to be fully clariﬁed [20], the results of the present
study begin to shed some light on potential mechanisms, sug-
gesting that selenium has a multitude of positive eﬀects on
beta-cell gene expression, contributing to overall improve-
ments in islet function. Further study is now required to fully
deﬁne the transcriptional targets and potential cell signalling
mechanisms central to this process.
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